Therapy News and Research

RSS

Neurosurgeons implant new type of electrical stimulator to control seizures

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy.

20 Jun 2014

Arthritis drug promotes hair growth in hairless man

A man with almost no hair on his body has grown a full head of it after a novel treatment by doctors at Yale University.

20 Jun 2014

Men with prostate cancer achieve stronger muscles and remain active through playing football

Men with prostate cancer aged 43‒74 achieve bigger and stronger muscles, improve functional capacity, gain positive social experiences and the desire to remain active through playing football for 12 weeks.

20 Jun 2014

Clinical trial shows that selumetinib drug can delay progression of metastatic uveal melanoma

For the first time, a therapy has been found that can delay progression of metastatic uveal melanoma, a rare and deadly form of melanoma of the eye.

20 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

Playing football could help lower blood pressure in women aged 35-50

The World Cup in Brazil may be attracting a global armchair audience of millions, but new research has shown that playing football could help lower blood pressure in women aged 35-50.

20 Jun 2014

CBT reduces urge to obey command hallucinations

The COMMAND trial shows that cognitive behaviour therapy can bring about a “clinically meaningful” reduction in the rate at which patients comply with command hallucinations.

19 Jun 2014

March of Dimes Canada, U of T sign deal to advance research in brain injuries, stroke

Today, March of Dimes Canada and the University of Toronto (U of T) signed a $1.5 million agreement to advance research in recovery from brain injuries and stroke, making the donation to the University the largest made by the national charitable organization in its over 60 year history.

19 Jun 2014

Review on effects of treating cholera with antimicrobial drugs

Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.

19 Jun 2014

Researchers find shared genetic link in autoimmune response among PV patients

Autoimmune disease occurs when the body's own natural defense system rebels against itself. One example is pemphigus vulgaris (PV), a blistering skin disease in which autoantibodies attack desmoglein 3 (Dsg3), the protein that binds together skin cells.

19 Jun 2014

New article explores ethical issues and global health impact of counterterrorism

The surge in murders of polio vaccination workers in Pakistan has made headlines this year, but little attention has been devoted to the ethical issues surrounding the global health impact of current counterterrorism policy and practice. An essay in the Hastings Center Report reviews the range of harms to population health traceable to counterterrorism operations.

19 Jun 2014

Apitope starts preclinical development of ATX-GD-459 for Graves' disease treatment

Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.

19 Jun 2014

UT Arlington researchers use portable device to map brain activity responses during cognitive activities

UT Arlington researchers have successfully used a portable brain-mapping device to show limited prefrontal cortex activity among student veterans with Post Traumatic Stress Disorder when they were asked to recall information from simple memorization tasks.

19 Jun 2014

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

UC Irvine Health will use a $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to examine the "Transition of Care in Chronic Kidney Disease (CKD)."

19 Jun 2014

Children may benefit from targeted treatments specific to pediatric brain activity

A new study from Bradley Hospital has found that bipolar children have greater activation in the right amygdala - a brain region very important for emotional reaction - than bipolar adults when viewing emotional faces.

19 Jun 2014

Drug therapy for ADHD does not entail increased risk of suicide attempts

A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).

19 Jun 2014

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.

18 Jun 2014

Walgreens, Heritage Provider Network sign clinical care collaboration agreement

Walgreens, the nation's largest drugstore chain, and global health care leader Heritage Provider Network, along with its Arizona operating affiliate Arizona Priority Care, today announced a clinical care collaboration agreement.

18 Jun 2014

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Laborie Medical Technologies, Inc., based in Toronto, Ontario, has completed its acquisition of BUCK Elektromedizin GmbH and BUCKmeditec GmbH & Co. Bad Rappenaeau, Germany based BUCK develops and distributes innovative and advanced biofeedback and electrical stimulation equipment, accessories and consumables for pelvic floor dysfunction in the treatment of urinary and fecal incontinence.

18 Jun 2014

Scientists advise caution with regard to artificial insemination method

Mitochondria are cell organelles located within animal and human cells. They produce energy for the organism, possess their own genetic material - mitochondrial DNA (mtDNA) - and are transmitted exclusively by the mother. Depending on their activity and tasks, different numbers of mitochondria are present in a cell - usually a few hundred to a thousand per body cell.

18 Jun 2014

Therapy News and Research

Neurosurgeons implant new type of electrical stimulator to control seizures

Arthritis drug promotes hair growth in hairless man

Men with prostate cancer achieve stronger muscles and remain active through playing football

Clinical trial shows that selumetinib drug can delay progression of metastatic uveal melanoma

New driver of atherosclerosis may prove to be promising therapeutic target

Playing football could help lower blood pressure in women aged 35-50

CBT reduces urge to obey command hallucinations

March of Dimes Canada, U of T sign deal to advance research in brain injuries, stroke

Review on effects of treating cholera with antimicrobial drugs

Researchers find shared genetic link in autoimmune response among PV patients

New article explores ethical issues and global health impact of counterterrorism

Apitope starts preclinical development of ATX-GD-459 for Graves' disease treatment

UT Arlington researchers use portable device to map brain activity responses during cognitive activities

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

Children may benefit from targeted treatments specific to pediatric brain activity

Drug therapy for ADHD does not entail increased risk of suicide attempts

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

Walgreens, Heritage Provider Network sign clinical care collaboration agreement

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Scientists advise caution with regard to artificial insemination method

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News